Axon director Cullivan to leave Board at 2026 meeting

Q: What board change did Axon (AXON) disclose in this 8-K filing?

Axon disclosed that director Julie Anne Cullivan will not stand for re-election at the 2026 Annual Meeting of Shareholders. She will remain on the Board until her current term expires at that meeting, ensuring continuity during the transition period.

Q: Why is Axon director Julie Anne Cullivan leaving the Board?

Axon states that Julie Anne Cullivan chose not to stand for re-election at the 2026 Annual Meeting. The company specifically notes her decision was not due to any disagreement about Axon’s operations, policies, or practices, indicating an orderly and amicable transition.

Q: When will Julie Anne Cullivan’s term as Axon (AXON) director end?

Julie Anne Cullivan’s term will end at Axon’s 2026 Annual Meeting of Shareholders. She will continue serving as a director until that meeting, providing ongoing participation in Board activities and governance through the remainder of her elected term.

Q: Did Axon report any disagreement with Julie Anne Cullivan in this 8-K?

No. Axon explicitly states that Ms. Cullivan’s decision not to stand for re-election was not the result of any disagreement with the company on operations, policies, or practices, suggesting her departure is not tied to a governance or policy dispute.

Q: How did Axon’s Board characterize Julie Anne Cullivan’s service?

Axon’s Board expressed strong appreciation for Julie Anne Cullivan’s service, highlighting her deep commitment, leadership, and contributions to the company’s growth and progress. This language underscores a positive assessment of her tenure and a respectful Board relationship.

Q: What SEC item does Axon use to report this board change?

Axon reported this information under Item 5.02, which covers departures and elections of directors, appointments of certain officers, and related compensatory arrangements. This item is commonly used to disclose material changes in board or senior officer roles.

Axon Enterprise, Inc. reported that director Julie Anne Cullivan has informed the Board that she will not stand for re-election at the company’s 2026 Annual Meeting of Shareholders.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Axon Enterprise, Inc. reported that director Julie Anne Cullivan has informed the Board that she will not stand for re-election at the company’s 2026 Annual Meeting of Shareholders. She will continue to serve as a director until her current term expires at that meeting.

The company states that Ms. Cullivan’s decision is not due to any disagreement with Axon regarding its operations, policies, or practices. The Board expressed strong appreciation for her commitment, leadership, and contributions to Axon’s growth and progress during her years of service.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Axon (AXON) disclose in this 8-K filing?

Axon disclosed that director Julie Anne Cullivan will not stand for re-election at the 2026 Annual Meeting of Shareholders. She will remain on the Board until her current term expires at that meeting, ensuring continuity during the transition period.

Why is Axon director Julie Anne Cullivan leaving the Board?

Axon states that Julie Anne Cullivan chose not to stand for re-election at the 2026 Annual Meeting. The company specifically notes her decision was not due to any disagreement about Axon’s operations, policies, or practices, indicating an orderly and amicable transition.

When will Julie Anne Cullivan’s term as Axon (AXON) director end?

Julie Anne Cullivan’s term will end at Axon’s 2026 Annual Meeting of Shareholders. She will continue serving as a director until that meeting, providing ongoing participation in Board activities and governance through the remainder of her elected term.

Did Axon report any disagreement with Julie Anne Cullivan in this 8-K?

No. Axon explicitly states that Ms. Cullivan’s decision not to stand for re-election was not the result of any disagreement with the company on operations, policies, or practices, suggesting her departure is not tied to a governance or policy dispute.

How did Axon’s Board characterize Julie Anne Cullivan’s service?

Axon’s Board expressed strong appreciation for Julie Anne Cullivan’s service, highlighting her deep commitment, leadership, and contributions to the company’s growth and progress. This language underscores a positive assessment of her tenure and a respectful Board relationship.

What SEC item does Axon use to report this board change?

Axon reported this information under Item 5.02, which covers departures and elections of directors, appointments of certain officers, and related compensatory arrangements. This item is commonly used to disclose material changes in board or senior officer roles.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/11/2026 - 04:44 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________________________

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

March 5, 2026

Date of Report (Date of earliest event reported)

________________________________________________________

Axon Enterprise, Inc.

(Exact name of registrant as specified in its charter)


Delaware	001-16391	86-0741227
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

17800 N. 85th St.

Scottsdale, Arizona 85255

(Address of principal executive offices, including zip code)

(480) 991-0797

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.00001 Par Value	AXON	The NASDAQ Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 5, 2026, Julie Anne Cullivan notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that she will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Ms. Cullivan will continue to serve as a director until her term expires at the Annual Meeting. Ms. Cullivan’s decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

The Board greatly appreciates Ms. Cullivan’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during her years of service.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: March 11, 2026	Axon Enterprise, Inc.

	By:	/s/ ISAIAH FIELDS
		Isaiah Fields Chief Legal Officer and Corporate Secretary

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents